 Hepatocellular biliary expression HLA antigens primary biliary cirrhosis ursodeoxycholic acid therapy reports ursodeoxycholic acid UDCA therapy beneficial effect liver function patients primary biliary cirrhosis information effects UDCA therapy hepatic histology insufficient Aberrant expression HLA antigens hepatocytes regarded important progression hepatocellular damages cytotoxic T-cells primary biliary cirrhosis study hepatocellular expression HLA antigens hepatocytes UDCA therapy patients asymptomatic primary biliary cirrhosis Piecemeal necrosis intralobular focal necrosis portal inflammation infiltration activated T-lymphocytes expression HLA class hepatocytes parallel therapy patients expression HLA-DR periportal hepatocytes therapy therapy observations UDCA therapy hepatocellular expression HLA antigens thereby reduces abolishes T-cell-mediated hepatocellular necrosis primary biliary cirrhosis